VG-1000 — A Therapeutic Vaccine for Cancer
This paper discusses the treatment of carcinoma with a vaccine made from human placenta. The Russian physician and immunologist, Valentin I. Govallo, concluded twenty years ago that cancer does not reflect immunodepression of the host organism. However, the tumor is capable of selectively “turning off host defenses. In this it resembles the fetus in utero, which is also capable of “turning off” or “blocking” the action of the maternal immune system. Govallo further concluded that cancer is best treated not by enhancing the host immune system but by suppressing the defense mechanisms of the malignant tumor. This is done by injecting an extract made from the human placenta collected after a normal live birth; the extract apparently acts as a “vaccine” which, perhaps through production of antibodies and immune complexes, neutralizes the tumor defenses (“blockers”). We discuss the theory underlying the use of the Govallo extract (known as VG-1000) and present the results of cases treated by us in Moscow in 1994 and in the Bahamas in 1995 and 1996. Reference is made to the Law of Cure which is, in many cases, exemplified by the patient histories given below.
KeywordsHuman Placenta Host Immune System Blood Type Therapeutic Vaccine Maternal Immune System
Unable to display preview. Download preview PDF.
- Valentin I. Govallo, Immunology of Pregnancy and Cancer. Commack, NY: Nova Science Publishers, Inc., 1993. Address of publisher: 6080 Jericho Turnpike, Suite 207. Commack, New York 11725.Google Scholar